Letter
Prevention of coronary heart disease
Cite this as:
BMJ
2004;328:405.3
Data in table 2 could be shown more explicitly for better understanding
- Andrea Messori, coordinator (andreamessori@interfree.it),
- Benedetta Santarlasci, researcher
- Laboratorio SIFO di Farmacoeconomia, Careggi University Hospital, 50134 Florence, Italy
EDITOR—The cost effectiveness study published by Marshall is difficult to understand in its technical details not only by average readers but also people with some skill in …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012